Wellington Management Group
NTLA icon

Wellington Management Group’s Intellia Therapeutics NTLA Stock Holding History

Wellington Management Group’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$736K Buy
43,484
+1,125
+3% +$15.7K ﹤0.01% 1792
2026
Q1 		$543K Buy
+42,359
New +$540K ﹤0.01% 1766
2025
Q4 		– Sell
-44,529
Closed -$769K – 2026
2025
Q3 		$769K Buy
+44,529
New +$548K ﹤0.01% 1825
2025
Q1 		– Sell
-699,814
Closed -$8.16M – 2017
2024
Q4 		$8.16M Buy
699,814
+55,051
+9% +$859K ﹤0.01% 1251
2024
Q3 		$13.2M Sell
644,763
-137,011
-18% -$3.16M ﹤0.01% 1088
2024
Q2 		$17.5M Sell
781,774
-3,380,355
-81% -$80.5M ﹤0.01% 997
2024
Q1 		$115M Buy
4,162,129
+1,705,212
+69% +$47.4M 0.02% 521
2023
Q4 		$74.9M Sell
2,456,917
-195,077
-7% -$5.61M 0.01% 622
2023
Q3 		$83.9M Buy
2,651,994
+36,630
+1% +$1.42M 0.02% 576
2023
Q2 		$107M Sell
2,615,364
-350,776
-12% -$14.2M 0.02% 532
2023
Q1 		$111M Buy
2,966,140
+971,952
+49% +$38.1M 0.02% 516
2022
Q4 		$69.6M Buy
1,994,188
+1,418,896
+247% +$67.5M 0.01% 606
2022
Q3 		$32.2M Sell
575,292
-84,607
-13% -$5.25M 0.01% 776
2022
Q2 		$34.2M Sell
659,899
-118,613
-15% -$6.02M 0.01% 789
2022
Q1 		$56.6M Buy
778,512
+167,764
+27% +$14.2M 0.01% 722
2021
Q4 		$72.2M Buy
610,748
+26,940
+5% +$3.37M 0.01% 720
2021
Q3 		$78.3M Buy
583,808
+268,167
+85% +$40.6M 0.01% 691
2021
Q2 		$51.1M Buy
+315,641
New +$24.6M 0.01% 819

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Wellington Management Group's NTLA Position: Q2 2026 in Review

Wellington Management Group increased its Intellia Therapeutics (NTLA) stake by 2.7% in Q2 2026, buying an estimated $15.7K and bringing the position to 43,484 shares worth $736K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Wellington Management Group first reported a position in NTLA in Q2 2021 and has held it in 18 quarters since. The position peaked at $115M in Q1 2024. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Wellington Management Group held 43,484 shares of Intellia Therapeutics worth $736K as of Q2 2026.
  • Wellington Management Group bought 1,125 Intellia Therapeutics shares in Q2 2026, an estimated $15.7K.
  • Intellia Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1792 holding.
  • Wellington Management Group first reported a position in Intellia Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • Wellington Management Group's Intellia Therapeutics position peaked at $115M in Q1 2024.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.